Clinical characteristics of cardiovascular patients with extremely low levels of high-density lipoprotein cholesterol

被引:0
|
作者
Sun, Lufan [1 ]
Duan, Lian [1 ]
Jia, Dalin [1 ]
机构
[1] China Med Univ, Hosp 1, Dept Cardiol, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
High-density lipoprotein cholesterol; Extreme; Low; Inflammation; Adverse factor; LOW HDL-CHOLESTEROL; SERUM URIC-ACID; INFLAMMATION; PREVALENCE; ALBUMIN; OBESITY; DYSLIPIDEMIA; ASSOCIATIONS; BIOMARKERS; SMOKING;
D O I
10.1186/s12944-021-01583-w
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Extremely low levels of high-density lipoprotein cholesterol (HDL-C) are related to high cardiovascular mortality. The underlying mechanism is not well known. This research aims to study the clinical characteristics of cardiovascular patients with extremely low levels of HDL-C. Methods All cardiovascular patients in a single Chinese cardiology center that were admitted from January to December 2019 were reviewed. The clinical characteristics of those with HDL-CResults A total of 20,655 individuals were enrolled. Of these, 52.17 % were males, and the average age was 58.20 +/- 12.98 years old. The prevalence of HDL-C<20 mg/dL was 0.47 % for all patients (N=98) and 1.05 % for inpatients. Of those with HDL-C<20 mg/dL, 88.8 % were inpatients, and 77.6 % were males. Their average age was 60.7 +/- 15.1 years. Compared with matched patients with normal HDL-C, systemic inflammation (OR= 5.556, 95% CI 2.798-11.030), hypoalbuminemia (OR=5.714, 95% CI 2.702-12.085), hyperuricemia (OR=5.156, 95% CI 2.560-10.386), low T3 syndrome (OR=4.278, 95% CI 1.627-11.245), anemia (OR=3.577, 95% CI 1.680-7.617), diabetes (OR=3.534, 95% CI 1.693-7.376) and hypertriglyceridemia (OR=2.493, 95% CI 1.264-4.918) were identified as adverse concomitant factors of extremely low HDL-C. HDL-C levels were inversely correlated with the total risk scores in patients with HDL-C<20 mg/dL (r=-0.381, P<0.001) and more significantly correlated in patients with HDL-C<15 mg/dL (r=-0.511, P=0.004). Conclusions Extremely low levels of HDL-C tend to occur more frequently in males, older individuals and inpatients. For cardiovascular patients, extremely low levels of HDL-C are usually due to the presence of multiple adverse factors with relatively severe conditions. This could explain the high cardiovascular mortality of individuals with extremely low levels of HDL-C.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Low levels of high-density lipoprotein cholesterol are a marker of disability in the elderly
    Zuliani, G
    Romagnoni, F
    Bollini, C
    Leoci, V
    Soattin, L
    Fellin, R
    GERONTOLOGY, 1999, 45 (06) : 317 - 322
  • [22] New perspectives on the management of low levels of high-density lipoprotein cholesterol
    Harper, CR
    Jacobson, TA
    ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) : 1049 - 1057
  • [23] Case 2: A patient with low levels of high-density lipoprotein cholesterol
    Friedewald, VE
    Gotto, AM
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (03): : 403 - 403
  • [24] Low serum levels of high-density lipoprotein cholesterol and hypolipidaemic treatment
    Kolovou, GD
    Cokkinos, DV
    CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (05) : 265 - 268
  • [25] XANTHELASMA - CLINICAL INDICATOR OF DECREASED LEVELS OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL
    BATES, MC
    WARREN, SG
    SOUTHERN MEDICAL JOURNAL, 1989, 82 (05) : 570 - 574
  • [26] Aspirin resistance is related to high-density lipoprotein cholesterol levels and total cholesterol/high-density lipoprotein ratio
    Coma-Canella, I
    Cordero, A
    Velasco, A
    Azcárate, P
    Castaño, S
    Palazuelos, J
    Martín, D
    Mejía, S
    EUROPEAN HEART JOURNAL, 2003, 24 : 370 - 370
  • [27] Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
    Hausenloy, D. J.
    Yellon, D. M.
    HEART, 2008, 94 (06) : 706 - 714
  • [28] Increasing high-density lipoprotein cholesterol levels for cardiovascular benefit: The end of a dream?
    Pirillo, Angela
    Catapano, Alberico Luigi
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (05) : 531 - 532
  • [29] Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?
    Dean, BB
    Borenstein, JE
    Henning, JM
    Knight, K
    Merz, CNB
    AMERICAN HEART JOURNAL, 2004, 147 (06) : 966 - 976
  • [30] Very High Levels of High-Density Lipoprotein Cholesterol and Cardiovascular Events in Japanese Population
    Masuda, Daisaku
    Yamashita, Shizuya
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (07) : 771 - 772